Waterloo Capital, L.P.

Position in ABBV — AbbVie Inc.

CIK 1730942 Austin, TX

Position in ABBV

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$5,872,019

+$1,292,985 QoQ

Shares Held

23,335

+10.8% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.74%

of 13F equity value

Holder Rank

#1,216

of 4,153 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Waterloo Capital, L.P. holds $23,385,515 across 8 Drug Manufacturers - General names. ABBV ranks #2 (25.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	24,785	$6,294,646
2	ABBV	AbbVie Inc. This page	23,335	$5,872,019
3	LLY	ELI LILLY & Co	4,584	$5,498,187
4	MRK	Merck & Co., Inc.	27,308	$3,509,078
5	PFE	Pfizer Inc	28,858	$694,900
6	BMY	Bristol Myers Squibb Co	9,856	$567,902
7	GILD	Gilead Sciences, Inc.	3,755	$474,406
8	AMGN	Amgen Inc	1,310	$474,377

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,872,019	23,335	+10.8%	Shares	Sole	2026-07-29
2026-03-31	$4,579,034	21,054	-6.1%	Shares	Sole	2026-05-12
2025-12-31	$5,124,573	22,428	+2.0%	Shares	Sole	2026-02-10
2025-09-30	$5,091,796	21,991	+6.7%	Shares	Sole	2025-11-05
2025-06-30	$3,827,298	20,619	+11.5%	Shares	Sole	2025-08-12
2025-03-31	$3,876,120	18,500	+20.3%	Shares	Sole	2025-05-12
2024-12-31	$2,732,137	15,375	+2.0%	Shares	Sole	2025-02-13
2024-09-30	$2,975,628	15,068	+38.6%	Shares	Sole	2024-11-14
2024-06-30	$1,864,593	10,871	-11.2%	Shares	Sole	2024-08-12
2024-03-31	$2,228,357	12,237	+0.8%	Shares	Sole	2024-05-14
2023-12-31	$1,881,645	12,142	+571.2%	Shares	Sole	2024-02-13
2023-09-30	$269,649	1,809	-28.5%	Shares	Sole	2023-11-14
2023-03-31	$403,046	2,529	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.